Stem cell therapy enriched with a bone-regenerating hormone, insulin-like growth factor-I (IGF-I), can help mend broken bones in fractures that are not healing normally. The findings are promising for children with brittle bone disease and elderly adults with osteoporosis because their fragile bones can easily and repeatedly break, and bone graft surgical treatment is often not successful or feasible.
Read more at Endocrine Society/newswise